Cargando…

Reduced Hypoxia Risk in a Systemic Sclerosis Patient with Interstitial Lung Disease after Long-Term Pulmonary Rehabilitation

Pulmonary rehabilitation is effective for improving exercise capacity in patients with interstitial lung disease (ILD), and most programs last about 8 weeks. A 43-year-old male patient with systemic sclerosis and oxygen saturation (SpO(2)) declining because of severe ILD was hospitalized for treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mugii, Naoki, Someya, Fujiko, Hasegawa, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210624/ https://www.ncbi.nlm.nih.gov/pubmed/22084615 http://dx.doi.org/10.4137/CCRep.S8071

Ejemplares similares

Ability of the COPD Assessment Test to evaluate the lung‐specific quality of life in systemic sclerosis‐associated interstitial lung disease
por: Mugii, Naoki, et al.
Publicado: (2020)

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
por: Someya, Fujiko, et al.
Publicado: (2013)

The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease
por: Someya, Fujiko, et al.
Publicado: (2016)

Exercise capacity in relation to autoantibodies in systemic sclerosis patients
por: Someya, Fujiko, et al.
Publicado: (2012)

Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies
por: Mugii, Naoki, et al.
Publicado: (2018)

Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly
por: Someya, Fujiko, et al.
Publicado: (2015)

Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies
por: Mugii, Naoki, et al.
Publicado: (2016)

Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial
por: Perez-Bogerd, Silvia, et al.
Publicado: (2018)

Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric study
por: Gonçalves Júnior, Jucier, et al.
Publicado: (2022)

Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias
por: Wallaert, Benoit, et al.
Publicado: (2019)

Pulmonary rehabilitation for interstitial lung disease: Referral and patient experiences
por: Hoffman, Mariana, et al.
Publicado: (2021)

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
por: Caron, Melissa, et al.
Publicado: (2018)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
por: Martín-López, María, et al.
Publicado: (2023)

Long-term macrolides in diffuse interstitial lung diseases
por: Faverio, Paola, et al.
Publicado: (2017)

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study
por: Simeón-Aznar, C.P, et al.
Publicado: (2008)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Interstitial Lung Disease Secondary to Long-Term Nitrofurantoin Use
por: Chin, Andrew J., et al.
Publicado: (2020)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis–Related Interstitial Lung Disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020)

Seasonal changes in activity levels among nursing care insurance service users in areas with different climates
por: Yamasaki, Masaya, et al.
Publicado: (2015)

Changes in ground reaction force during a rebound-jump task after hip strength training for single-sided ankle dorsiflexion restriction
por: Kondo, Hitoshi, et al.
Publicado: (2016)

Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
por: Kreuter, Michael, et al.
Publicado: (2023)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
por: Zheng, Boyang, et al.
Publicado: (2023)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Combined effect of pulmonary rehabilitation and music therapy in patients with chronic obstructive pulmonary disease
por: Okamoto, Jun, et al.
Publicado: (2021)

Early Intervention of Pulmonary Rehabilitation for Fibrotic Interstitial Lung Disease Is a Favorable Factor for Short-Term Improvement in Health-Related Quality of Life
por: Matsuo, Satoshi, et al.
Publicado: (2021)

Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
por: Tonelli, Roberto, et al.
Publicado: (2017)

Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety
por: Mendes, Renata G., et al.
Publicado: (2021)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
por: Sangani, Ruchika A., et al.
Publicado: (2022)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
por: Waxman, Aaron, et al.
Publicado: (2023)

Pulmonary Ultrasonography in Systemic Sclerosis-Induced Interstitial Lung Disease—A Systematic Review and Meta-Analysis
por: Radić, Mislav, et al.
Publicado: (2023)

Effectiveness of Pulmonary Rehabilitation in Interstitial Lung Disease, Including Coronavirus Diseases: A Systematic Review and Meta-analysis
por: Reina-Gutiérrez, Sara, et al.
Publicado: (2021)

Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease
por: Chen, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4bfbsjjpei7d2c1p52e8k3b0g8